Form 8-K LEMAITRE VASCULAR INC For: Feb 23
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall St mixed as Middle East tensions eclipse tech strength
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Lemaitre Vascular (LMAT) Misses Q4 EPS by 1c, Offers Guidance
February 23, 2023 3:56 PM ESTLemaitre Vascular (NASDAQ: LMAT) reported Q4 EPS of $0.25, $0.01 worse than the analyst estimate of $0.26. Revenue for the quarter came in at $41 million versus the consensus estimate of $41 million.
GUIDANCE:
Lemaitre Vascular sees Q1 2023 EPS of $0.22-$0.27, versus the consensus of... More
